Practice
Featured experience
Aptiv $2.15 billion senior notes and junior subordinated notes offerings
We advised Aptiv on the SEC-registered offerings of senior notes and fixed-to-fixed reset rate junior subordinated notes
Devon Energy $2.25 billion notes offering
The company intends to use a portion of the proceeds to fund its pending acquisition of Grayson Mill
PPL Capital Funding $750 million senior notes offering
The 5.250% investment-grade senior notes are due 2034
Plug Power $200 million stock offering
The shares are traded on Nasdaq
Energizer Holdings $800 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by…
Advance Auto Parts $350 million notes offering and concurrent cash tender offer
Davis Polk advised the joint book-running managers in connection with an offering by Advance Auto Parts, Inc. of $350…
Hologic $950 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by…
YUM! Brands $1.05 billion senior notes offering
Davis Polk advised the representative of the underwriters in connection with an SEC-registered offering by YUM! Brands,…
Emerson Electric $750 million notes offering
Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Emerson Electric…
Schlumberger $500 million notes offering
Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Schlumberger Finance…
Murray Energy restructuring consummated
Davis Polk advised an ad hoc group of lenders (the “Ad Hoc Group”) to Murray Energy Corporation (together with certain of…
UMB Financial $200 million notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by UMB…
PDC Energy $150 million notes offering
Davis Polk advised the representative of the underwriters in connection with a registered offering of $150 million aggregate…
Gilead Sciences $21 billion acquisition of Immunomedics
Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The…